Article
Genetic and Nongenetic Factors Affecting Clopidogrel Response in the Egyptian Population.
Clinical and translational science - 1 Feb 2016
Khalil B M, Shahin M H, Solayman M H M, Langaee T, Schaalan M F, Gong Y, Hammad L N, Al-Mesallamy H O, Hamdy N M, El-Hammady W A, Johnson J A
Abstract excerpt
Aspirin and clopidogrel are the mainstay oral antiplatelet regimens, yet a substantial number of major adverse cardiac events (MACE) still occur. Herein, we investigated genetic and nongenetic factors associated with clopidogrel response in Egyptians. In all, 190 Egyptians with acute coronary syndrome (ACS) and/or percutaneous coronary intervention (PCI), treated with clopidogrel (75 mg/day) for at least a month,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.